Adenosine 2A receptor (A 2A R) exerts protective roles in endotoxin-and/or ischemia-induced tissue damage. However, the role for A 2A R in nonalcoholic fatty liver disease (NAFLD) remains largely unknown. We sought to examine the effects of global and/or myeloid cell-specific A 2A R disruption on the aspects of obesity-associated NAFLD and to elucidate the underlying mechanisms. Global and/or myeloid cell-specific A 2A R-disrupted mice and control mice were fed a high-fat diet (HFD) to induce NAFLD. In addition, bone marrow-derived macrophages and primary mouse hepatocytes were examined for inflammatory and metabolic responses. Upon feeding an HFD, both global A 2A R-disrupted mice and myeloid cell-specific A 2A R-defcient mice revealed increased severity of HFD-induced hepatic steatosis and inflammation compared with their respective control mice. In in vitro experiments, A 2A R-deficient macrophages exhibited increased proinflammatory responses, and enhanced fat deposition of wild-type primary hepatocytes in macrophage-hepatocyte cocultures. In primary hepatocytes, A 2A R deficiency increased the proinflammatory responses and enhanced the effect of palmitate on stimulating fat deposition. Moreover, A 2A R deficiency significantly increased the abundance of sterol regulatory element-binding protein 1c (SREBP1c) in livers of fasted mice and in hepatocytes upon nutrient deprivation. In the absence of A 2A R, SREBP1c transcription activity was significantly increased in mouse hepatocytes. Conclusion: Taken together, our results demonstrate that disruption of A 2A R in both macrophage and hepatocytes accounts for increased severity of NAFLD, likely through increasing inflammation and through elevating lipogenic events due to stimulation of SREBP1c expression and transcription activity. (HEPATOLOGY 2018;68:48-61).
H epatic steatosis is a hallmark of nonalcoholic fatty liver disease (NAFLD). (1, 2) When the liver develops overt inflammatory damage, simple steatosis progresses to nonalcoholic steatohepatitis (NASH). (2, 3) The latter is the advanced form of NAFLD and is considered as a leading causal factor of cirrhosis and hepatocellular carcinoma. (4, 5) In addition, NAFLD critically contributes to the development of dyslipidemia and significantly increases the incidence of atherogenic cardiovascular diseases, (6) thereby serving as a key component of metabolic syndrome. (7) Numerous studies of both human subjects and rodent models demonstrate that obesity significantly increases the incidence of NAFLD. (8) (9) (10) Accordingly, obesity-associated inflammation is accepted as a critical factor that initiates or exacerbates NAFLD. For instance, inflammation can cause hepatic insulin resistance, which, in turn elevates hepatic steatosis, at least in part, through increasing the expression of genes for lipogenic enzymes such as acetyl-coenzyme A carboxylase 1 (ACC1) and fatty acid synthase (FAS) and decreasing the expression of genes for fatty acid oxidation, including carnitine palmitoyltransferase 1a (CPT1a). (11) (12) (13) In addition, proinflammatory mediators (e.g., cytokines) can exert direct effects on hepatocytes to increase lipogenic events (14) and act on both hepatocytes and liver macrophages/Kupffer cells to accelerate liver inflammation. This exemplifies how inflammation serves as "a second hit" to drive the progression of simple steatosis to NASH. However, exactly how inflammation is regulated in the context of NAFLD pathophysiology remains largely unclear.
Adenosine receptors, including A 1 , A 2A , A 2B , and A 3 , belong to the superfamily of G-protein-coupled receptors and mediate various physiological functions of adenosine. (15) Among the four adenosine receptors, adenosine 2A receptor (A 2A R) displays powerful antiinflammatory effects in immune cells such as macrophages and neutrophils. (15, 16) Several studies in animal models have indicated that A 2A R deficiency exacerbates concanavalin A-or endotoxin-induced liver damage, which is attributable to prolonged and enhanced expression of proinflammatory cytokines including tumor necrosis factor a (TNFa) and interleukin-6 (IL-6). (17) Also, a recent study has shown that A 2A R deficiency exacerbates the severity of aspects of alcoholic fatty liver disease in mice. (18) Additionally, A 2A R activation displays beneficial effects on aspects of NASH in rodents, (19, 20) which is largely mediated through the anti-inflammatory effect of A 2A R. In contrast, treatment of mice with an A 2A R antagonist increased the severity of CCl 4 -induced liver fibrosis; although the same treatment reversed the effect of ethanol on exacerbating CCl 4 -induced liver fibrosis. (21) Collectively, these findings suggest that A 2A R has a protective role in liver damage. However, whether and how A 2A R coordinates hepatocyte and macrophage metabolic and/or inflammatory responses to alter NAFLD development and progression remains poorly understood. It is also not clear whether and how A 2A R regulates hepatocyte lipogenic events, whose increase is of particular importance in the pathogenesis of hepatic steatosis. The goal of the present study was to assess how global and/or myeloid cell-specific A 2A R disruption influences NAFLD aspects in mice, and the results support a protective role for the A 2A R in both macrophages and hepatocytes in the pathogenesis of obesity-associated NAFLD. In addition, A 2A R has a previously unidentified role in repressing sterol regulatory element-binding protein 1c (SREBP1c), which contributes to the antisteatotic effect of A 2A R.
Materials and Methods

ANIMAL EXPERIMENTS
Wild-type (WT) C57BL/6J mice were obtained from the Jackson Laboratory (Bar Harbor, ME).
, and A 2A R 1/1 mice were generated as described previously. (22) Myeloid cell-specific A 2A R-disrupted mice were generated using the CreLoxP strategy. Briefly, homozygous myeloid cell-spe-
) mice, and LysM control (LysMCre
1/1 ) mice were used. All mice were maintained on a 12/12-hour light-dark cycle (lights on at 6:00 AM) and subjected to studies involving chow-diet, high-fat diet (HFD, 60% fat calories) and low-fat diet (LFD, 10% fat calories) as detailed in Supplementary Information (SI). All study protocols were reviewed and approved by the Institutional Animal Care and Use Committee of Texas A&M University.
CELL CULTURE AND TREATMENT
Bone marrow cells were prepared from A 2A R-disrupted mice and WT mice, as well as LysMCre 1 -A 2A R F/F mice and LysMCre
1
-A 2A R 1/1 mice, and differentiated into macrophages (i.e., bone marrowderived macrophages [BMDMs] ) and examined for the proinflammatory activation as described previously. (23) Primary hepatocytes were isolated from freefed mice (24, 25) and examined for metabolic and inflammatory responses. For macrophage-hepatocyte coculture study, bone marrow cells were prepared from A 2A R-disrupted mice and WT mice 6 days before hepatocyte isolation. After differentiation, BMDMs were trypsinized and added to WT primary mouse hepatocytes at a ratio of 1:10 based on a previously published method. (12) Some hepatocytes were incubated in the absence of macrophages and served as the control. After incubation for 48 hours, the cocultures and control hepatocytes were subjected to the selected assays described in the Supporting Information. Additional experiments involving hepatocytes are also detailed in the Supporting Information.
HISTOLOGICAL, BIOCHEMICAL, AND MOLECULAR ASSAYS
Liver sections were subjected to histological and immunohistochemical assays. Plasma parameters were measured using metabolic assay kits and enzymelinked immunosorbent assay kits. In addition, tissue and/or cell samples were subjected to selected assays, including western blot analysis, real-time polymerase chain reaction (PCR), reporter assays, and chromatin immunoprecipitation assays. Additional details are provided in the Supporting Information.
STATISTICAL METHODS
Numerical data are presented as the mean 6 standard error (SE). Statistical significance was assessed by way of unpaired, two-tailed analysis of variance or Student t tests. Differences were considered significant at the two-tailed P < 0.05.
Results
HFD FEEDING INCREASES LIVER A 2A R ABUNDANCE AND THE PROINFLAMMATORY STATUS
Tissue distribution results revealed that the liver is one of the organs in which A 2A R abundance was at the highest levels (Fig. 1A) . We examined the pathophysiological relevance of hepatic expression of A 2A R in C57BL/6J mice, which display obesity-associated NAFLD upon feeding HFD. (9, 10) HFD-fed C57BL/ 6J mice displayed a significant increase in liver A 2A R messenger RNAs (mRNAs) compared with LFD-fed mice (Fig. 1B) . HFD-fed mice also displayed significant increases in liver protein levels of A 2A R, as well as CD39 and CD73 (ectoenzymes responsible for extracellular adenosine production) (Fig. 1C) . By immunohistochemistry in liver sections, HFD-fed mice revealed increased A 2A R expression in liver cells including hepatocytes compared with LFD-fed mice (Supporting Fig.  S1 ). Additionally, HFD-fed C57BL/6J mice displayed significant increases in liver phosphorylation states of cJun N-terminal kinase (JNK) p46 and nuclear factor kappa B (NF-jB) p65 as well as mRNA and protein levels of TNFa, interleukin 1b (IL-1b), and/or IL-6 compared with LFD-fed mice (Fig. 1D,E) . These results suggest an association between A 2A R amount and diet-induced liver inflammation.
A 2A R DISRUPTION EXACERBATES HFD-INDUCED HEPATIC STEATOSIS AND INFLAMMATION
The role of A 2A R in obesity-associated NAFLD remains largely unknown and was examined using both male and female A 2A R-disrupted (A 2A R -/-and/ or A 2A R Fig. S3-S6 ). Next, we examined the effect of A 2A R disruption on NAFLD pathology. Among male mice, HFD-fed A 2A R-disrupted mice revealed a greater increase in liver weight compared with control mice, and this increase was gene dose-dependent ( Fig. 2A) Fig. S7A,B) . Among female mice, A 2A R disruption caused a slight increase in the severity of HFD-induced hepatic steatosis without significantly altering liver weight (Supporting Fig. S7C ). For panels A, C, and D, liver lysates were used for western blot analysis. Blots were quantified using densitometry (bar graphs in panels C and D). For panels B and E, liver mRNAs were quantified using real-time reverse-transcription PCR. For panel E, liver protein levels of cytokines were quantified using enzyme-linked immunosorbent assay kits. For all bar graphs, data are presented as the mean 6 SE (n 5 6-8). Statistical difference between HFD and LFD: *P < 0.05 and **P < 0.01 in B and E (right two panels) or in bar graphs of C, D, and E (left panel) for the same protein or gene.
Because the HFD-induced phenotype in male mice was more pronounced, we examined other liver phenotypes (i.e., inflammation and insulin sensitivity, mainly in male mice). Upon HFD feeding, A 2A R-disrupted and control mice displayed comparable numbers of macrophages/Kupffer cells in the liver (Fig. 2B) . However, either HFD-fed A 2A R -/-mice or HFD-fed A 2A R 1/-mice revealed a significant increase in liver proinflammatory signaling through JNK p64 and/or NF-jB p65 (Fig. 2C) . The same trends were also observed in TNFa and IL-1b mRNAs (Fig. 2D ).
Because increased lipogenesis is key to the development of hepatic steatosis, we examined the mRNA levels of ACC1 and FAS, which are key enzymes that stimulate liver lipogenesis by converting acetyl-CoA to malonyl-CoA and synthesizing long-chain fatty acids. (26, 27) Compared with those in livers of HFD-fed A 2A R 1/1 mice, the mRNA levels of ACC1 and FAS in either HFD-fed A 2A R -/-mice or HFD-fed A 2A R 1/-mice were significantly elevated, and these elevations were A 2A R gene-dependent (Fig. 2D) . Additionally, hepatic mRNA levels of SREBP1c in HFD-fed A 2A R-disrupted mice were significantly elevated in an A 2A R gene-dependent manner (Fig. 2D) . We also measured hepatic mRNA levels of CPT1a, a master regulator that transfers acyl-CoA into mitochondria for oxidation. (28, 29) Compared with the control, CPT1a mRNAs in HFD-fed A 2A R -/-mice were slightly higher than in HFD-fed A 2A R (Fig. 3A,B) . Additionally, plasma and hepatic levels of triglycerides in HFD-fed LysMCre (Fig. 4A,B) . Similarly, LPS-induced phosphorylation states of JNK p46 and NFjB p65 in BMDMs from LysMCre 1 -A 2A R F/F mice were significantly increased compared with those in BMDMs from LysMCre (Fig. 4C) .
Next, we cocultured WT primary mouse hepatocytes with A 2A R -/-or A 2A R 1/1 BMDMs. Under palmitate-stimulated conditions, hepatocytes cocultured with A 2A R -/-BMDMs accumulated more fat and revealed significantly higher levels of triglycerides than hepatocytes cocultured in the absence of BMDMs or in the presence of A 2A R 1/1 BMDMs (Fig. 5A ). When the expression of genes/enzymes related to fat metabolism was analyzed, ACC1, FAS, and SREBP1c mRNAs in hepatocytes cocultured with A 2A R -/-BMDMs were significantly higher than their respective levels in hepatocytes cocultured in the absence of BMDMs or in the presence of A 2A R 1/1 BMDMs (Fig. 5B) . In contrast, CPT1a mRNAs in hepatocytes cocultured with A 2A R -/-BMDMs were significantly lower than those in hepatocytes cocultured in the absence of BMDM or in the presence of A 2A R (Fig. 5D ). Taken together, these results suggest that the A 2A R in macrophages protects against macrophage proinflammatory activation. The latter has detrimental effects on increasing hepatocyte fat deposition and proinflammatory responses and on impairing hepatocyte insulin sensitivity. 
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A 2A R DISRUPTION EXACERBATES HEPATOCYTE FAT DEPOSITION AND PROINFLAMMATORY RESPONSES
A 2A R appeared to play a protective role in NAFLD. Next, we examined the direct effects of A 2A R disruption on hepatocyte responses. When fat deposition was analyzed, hepatocytes from A 2A R -/-mice accumulated much more fat and revealed significantly higher levels of triglycerides than hepatocytes from A 2A R 1/-mice or A 2A R 1/1 mice under palmitate-stimulated conditions (Fig. 6A) . When proinflammatory signaling was analyzed, the phosphorylation states of JNK p46 and NFjB p65 in hepatocytes from A 2A R -/-mice were significantly stronger than those in hepatocytes from A 2A R 1/-mice or A 2A R 1/1 mice under LPS-stimulated conditions (Fig. 6B) . When insulin sensitivity was analyzed, the states of insulin-stimulated Akt phosphorylation in hepatocytes from A 2A R -/-or A 2A R 1/-mice were significantly lower than those in hepatocytes from A 2A R 1/1 mice (Fig. 6C) . Consistently, A 2A R inhibition increased hepatocyte fat deposition and proinflammatory responses, and decreased hepatocyte insulin signaling (Supporting Fig. S11 ). Taken together, these results indicate a direct role of A 2A R in protecting hepatocytes from palmitate-induced fat deposition and from LPSinduced proinflammatory responses. 
A 2A R DISRUPTION INCREASES THE EXPRESSION AND TRANSCRIPTION ACTIVITY OF SREBP1c
A 2A R disruption exacerbated hepatic steatosis and increased lipogenic events. To gain mechanistic insights for A 2A R regulation of lipogenesis, we examined the effect of A 2A R disruption on SREBP1c in mice and in isolated primary mouse hepatocytes. Because feeding increases the amount and/or transcription activity of SREBP1c, we examined whether A 2A R disruption alters the effect of feeding on SREBP1c. Compared with fasting, feeding caused a significant increase in the abundance of both cytosolic and nuclear SREBP1c in livers of A 2A R 1/1 mice, but not A 2A R -/-mice. Strikingly, the abundance of either cytosolic or nuclear SREBP1c in livers of A 2A R -/-mice was greater than that in livers of A 2A R 1/1 mice under fasted conditions, but not fed conditions (Fig.  7A) . Consistently, the abundance of cytosolic or nuclear SREBP1c was increased in hepatocytes from A 2A R -/-mice compared with that in hepatocytes from A 2A R 1/1 mice under conditions mimicking fasting (Fig. 7B) . We then performed the reporter assay and observed that SREBP1c transcription activity in hepatocytes from A 2A R -/-mice was significantly higher than that in hepatocytes from A 2A R basal conditions (in the absence of insulin) (Fig. 7C) . Similar changes were also observed in hepatocytes under insulin-stimulated conditions. However, insulin increased SREBP1c transcription activity in hepatocytes from A 2A R 1/1 but not A 2A R -/-mice. Next, we performed a chromatin immunoprecipitation assay. The binding of SREBP1c to SRE/E (a binding element in the FAS promoter region) increased significantly in nuclear extracts of hepatocytes from A 2A R -/-mice compared with that observed in hepatocytes from A 2A R 1/1 mice (Fig. 7C ). In addition, the mRNAs of key target genes of SREBP1c (e.g., glucokinase and FAS) were greater in hepatocytes from A 2A R -/-mice compared with those of hepatocytes from A 2A R 1/1 mice (Fig. 7D) . These results suggest that A 2A R is capable of repressing SREBP1c expression under fasted conditions and suppressing SREBP1c transcription activity.
We also examined the phosphorylation status of AMP-activated protein kinase (AMPK), a regulator that exerts a powerful antisteatotic effect. Compared with those in HFD-fed A 2A R 1/1 mice or A 2A R 1/-mice, hepatic phosphorylation states of AMPK in HFD-fed A 2A R -/-mice decreased significantly (Fig.  7E) . Because the cellular ADP:ATP ratio critically influences AMPK phosphorylation, we performed cellular assays and observed that the ADP:ATP ratios were significantly lower in hepatocytes from A 2A R -/-mice than in those of A 2A R 1/1 mice or A 2A R 1/-mice (Fig. 7F) . These results are consistent with changes in the status of hepatic steatosis.
Discussion
We established an association between A 2A R and obesity-associated NAFLD using HFD-fed WT mice, in which increased liver proinflammatory responses were accompanied by increased liver abundance of A 2A R. Considering that A 2A R activation exerts powerful anti-inflammatory effects, (19, 20, 30, 31) whereas A 2A R deficiency exacerbates proinflammatory responses, (32) we speculated that the increase in liver A 2A R abundance in HFD-fed WT mice was a defensive response. As substantial evidence, global A 2A Rdeficient mice displayed a significant increase in the severity of HFD-induced liver inflammation and other NAFLD aspects. Importantly, this evidence from A 2A R-deficient mice establishes a cause-and-effect relationship between A 2A R disruption and NAFLD. In global A 2A R-deficient mice, increased NAFLD aspects may be attributable to the lack of A 2A R in macrophages, hepatocytes, or both. Considering the importance of macrophages in regulating inflammation, we speculated that the A 2A R in macrophages was needed for protecting mice from obesity-associated NAFLD, and we found that this was the case. Therefore, our three lines of in vivo evidence make it conceivable that A 2A R acts, at least partially, by suppressing inflammation to protect against obesityassociated NAFLD.
Carini et al. showed that A 2A R activation ameliorates methionine-and choline-deficient diet (MCD)-induced NASH in rats. (19) A follow-up study confirmed the beneficial effect of A 2A R activation in MCD-fed mice, (20) which was associated with decreased proinflammatory responses in both hepatocytes and lymphocytes. These results suggest antiinflammation as an essential mechanism by which A 2A R activation improves NASH. However, these studies did not address how macrophages respond to A 2A R activation in the context of protecting against NASH. Indeed, the observed decreases in cytokine production by hepatic mononuclear cells of MCD-fed mice upon A 2A R activation could be secondary to the anti-inflammatory effects of A 2A R activation on hepatocytes and/or macrophages. Considering that macrophages have been implicated to critically determine the development and progression of obesity-associated NAFLD, (11, 12) it is necessary to address how the A 2A R in macrophages alters NAFLD aspects. In the present study, we confirmed that A 2A R disruption exacerbates macrophage proinflammatory activation. Moreover, we show that myeloid cell-specific A 2A R deficiency exacerbates HFD-induced hepatic steatosis and inflammation. Because A 2A R was disrupted only in myeloid cells, increased hepatic steatosis and inflammation in HFD-fed LysMCre 1 -A 2A R F/F mice appeared to be secondary to the consequences of A 2A R disruption in myeloid cells. As supporting evidence, hepatocytes cocultured with A 2A R-disrupted macrophages revealed significant increases in the expression of proinflammatory cytokines and in palmitateinduced fat deposition and in the expression of ACC1, FAS, and SREBP1c compared with hepatocytes cocultured with control macrophages. Because the initial differences among cocultures existed solely in macrophages (e.g., the presence or absence of A 2A R), the outcomes of hepatocyte lipogenic events were attributable to the effects secondary to A 2A R disruptionassociated increase in macrophage proinflammatory activation. The latter has been shown to generate macrophage-derived factors (i.e., proinflammatory cytokines) to promote hepatocyte lipogenic events, (14) enhance hepatocyte proinflammatory responses, and decrease hepatocyte insulin signaling. (33) Therefore, the results from myeloid cell-specific A 2A R-deficient mice and macrophage-hepatocyte cocultures demonstrate that A 2A R has a role in coordinating macrophage actions on hepatocytes to protect against NAFLD aspects.
A 2A R also critically regulates hepatocyte metabolic and inflammatory responses. In support of this, A 2A R disruption brought about deleterious effects on palmitate-induced fat deposition and LPS-induced proinflammatory responses in primary mouse hepatocytes. In addition, treatment of WT mouse hepatocytes with an A 2A R antagonist generated effects mimicking A 2A R disruption. These two lines of evidence not only recapitulate the findings in HFD-fed A 2A R-disrupted mice, but also serve as complementary evidence to support the anti-inflammatory and antisteatotic effects of A 2A R activation. (19, 20) However, it remains to be explored, within hepatocytes, whether and how the anti-inflammatory effect of A 2A R interplays with the antilipogenic effect of A 2A R. Given the coexistence of these effects of A 2A R, it is possible that A 2A R acts through suppressing hepatocyte inflammatory signaling to inhibit lipogenic events. Alternatively, A 2A R may act through two parallel pathways to suppress hepatocyte proinflammatory responses and to inhibit hepatocyte fat deposition.
It is a significant finding that A 2A R disruption elevated hepatic SREBP1c abundancy. Additionally, increased liver abundancy of SREBP1c in HFD-fed A 2A R-deficient mice was accompanied by increases in hepatic expression of lipogenic enzymes and in the severity of hepatic steatosis. These results are consistent with an established paradigm concerning the critical contribution of lipogenesis, at increased levels, to the development of hepatic steatosis. (34) (35) (36) Physiologically, hepatic SREBP1c is stimulated by feeding and repressed by fasting, (36) which accounts for increased hepatic fat content under fed states and decreased hepatic fat content under fasted states, respectively. Strikingly and interestingly, in the present study, A 2A R deficiency increased liver SREBP1c abundance under fasted conditions, where SREBP1c expression and activity should be suppressed physiologically. Consistently, A 2A R disruption increased the abundance of SREBP1c in hepatocytes upon nutrient deprivation. These findings support a repressive effect of A 2A R on SREBP1c. In addition to altering SREBP1c abundance, A 2A R disruption also decreased hepatic AMPK phosphorylation states, likely through a mechanism involving decreases in hepatocyte ADP:ATP ratio, because AMPK is activated by increased ratios of AMP:ATP and ADP:ATP. Considering the role of AMPK in phosphorylating and inactivating SREBP1c, (37) A 2A R deficiency-associated decreases in AMPK phosphorylation appeared to also contribute to the effects of A 2A R deficiency on increasing hepatic lipogenesis and on exacerbating hepatic steatosis. Indeed, at the cellular level, A 2A R disruption increased SREBP1c transcription activity and enhanced the binding of SREBP1c to the promoter region of FAS.
Collectively, our findings suggest that A 2A R signaling pathways are involved in repression of SREBP1c, which in turn contributes to the effects of A 2A R on suppressing lipogenic events and protecting against the development of hepatic steatosis.
In conclusion, we validated a protective role for A 2A R in obesity-associated NAFLD. Mechanistically, this role of A 2A R is attributable to the direct effects of A 2A R on altering inflammatory and metabolic responses of macrophages and hepatocytes. Specifically, A 2A R suppresses macrophage and hepatocyte proinflammatory responses. A 2A R suppression of macrophage activation also generates secondary effects on inhibiting the inflammatory responses and lipogenic events of hepatocytes. Finally, A 2A R can directly suppress hepatocyte fat deposition, which is attributable to the effects of A 2A R on repressing SREBP1c expression under fasted states and on suppressing SREBP1c transcription activity. Therefore, targeting A 2A R to suppress inflammation and lipogenesis is a viable therapeutic strategy for the treatment of NAFLD and inflammation-associated human liver diseases.
